Discernment of rare alleles in circulating free DNA (cfDNA) may be a useful method for detecting the presence of new or recurring cancer long before it becomes symptomatic and, perhaps, when it is more treatable. Unfortunately the false-positive rate of current methods reduce specificity to an unacceptable level at allele frequencies of less than ~0.5%.
Tissue and cfDNA Rare Alleles How Low Can We Go
Video Apr 28, 2015
New Tools, New Possibilities - 3D Printing for Lab-on-a-ChipVideo
Greg Nordin describes a breakthrough new method of making lab-on-a-chip devices by 3D printing.WATCH NOW
Comments | 0 ADD COMMENT
2nd Annual Artificial Intelligence in Drug Development Congress
Sep 20 - Sep 21, 2018